Molecular Templates Operating Margin vs. EBITDA
| MTEM Stock | USD 0.37 0.03 7.50% |
Molecular Templates Operating Profit Margin |
|
For Molecular Templates profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Molecular Templates to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Molecular Templates utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Molecular Templates's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Molecular Templates over time as well as its relative position and ranking within its peers.
Molecular |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Templates. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Templates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (3.05) | Revenue Per Share 4.544 | Quarterly Revenue Growth (0.92) | Return On Assets (0.38) |
The market value of Molecular Templates is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Templates' value that differs from its market value or its book value, called intrinsic value, which is Molecular Templates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Templates' market value can be influenced by many factors that don't directly affect Molecular Templates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Templates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Templates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Templates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Molecular Templates EBITDA vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Molecular Templates's current stock value. Our valuation model uses many indicators to compare Molecular Templates value to that of its competitors to determine the firm's financial worth. Molecular Templates is regarded fourth in operating margin category among its peers. It is considered to be number one stock in ebitda category among its peers . At this time, Molecular Templates' Operating Profit Margin is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Molecular Templates by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Molecular EBITDA vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Molecular Templates |
| = | (14.50) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Molecular Templates |
| = | 1.43 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Molecular EBITDA Comparison
Molecular Templates is currently under evaluation in ebitda category among its peers.
Molecular Templates Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Molecular Templates, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Molecular Templates will eventually generate negative long term returns. The profitability progress is the general direction of Molecular Templates' change in net profit over the period of time. It can combine multiple indicators of Molecular Templates, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -75.9 K | -79.7 K | |
| Operating Income | -10.5 M | -11 M | |
| Net Loss | -8.1 M | -8.5 M | |
| Income Tax Expense | -11 K | -10.4 K | |
| Income Before Tax | -8.1 M | -8.5 M | |
| Total Other Income Expense Net | 2.3 M | 2.2 M | |
| Net Loss | -26.2 M | -27.5 M | |
| Non Operating Income Net Other | -3.9 M | -4.1 M | |
| Net Loss | -83.4 M | -79.3 M | |
| Interest Income | 1.5 M | 892.5 K | |
| Net Interest Income | -2.6 M | -2.4 M | |
| Change To Netincome | 14.4 M | 7.4 M | |
| Net Loss | (1.80) | (1.90) | |
| Income Quality | 5.15 | 5.41 | |
| Net Income Per E B T | 1.00 | 1.13 |
Molecular Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Molecular Templates. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Molecular Templates position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Molecular Templates' important profitability drivers and their relationship over time.
Use Molecular Templates in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Molecular Templates position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Templates will appreciate offsetting losses from the drop in the long position's value.Molecular Templates Pair Trading
Molecular Templates Pair Trading Analysis
The ability to find closely correlated positions to Molecular Templates could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Molecular Templates when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Molecular Templates - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Molecular Templates to buy it.
The correlation of Molecular Templates is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Molecular Templates moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Molecular Templates moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Molecular Templates can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Molecular Templates position
In addition to having Molecular Templates in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy ETFs Thematic Idea Now
Energy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 92 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in Molecular Stock, please use our How to Invest in Molecular Templates guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
To fully project Molecular Templates' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Molecular Templates at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Molecular Templates' income statement, its balance sheet, and the statement of cash flows.